임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
42건 표시
- 1/2상조기 종료· Advanced Solid TumorSafety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients
리드: SK바이오팜
- 2상조기 종료· Marginal Zone LymphomaPembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
협력: 셀트리온
- 3상조기 종료· Severe COVID-19Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
리드: 대웅제약
- 1상조기 종료· COVID-19 PatientsTo Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
리드: 대웅제약
- 1상조기 종료· Cardiomyopathy, Hypertrophic ObstructiveA Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
리드: 셀트리온
- 2/3상조기 종료· Mild to Moderate COVID-19Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
리드: 대웅제약
- 3상조기 종료· Type 2 Diabetes MellitusEfficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
협력: 한미약품
- 1상조기 종료· Non Small Cell Lung CancerOlmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI
리드: 한미약품
- 1상조기 종료· Type 2 Diabetes MellitusMultiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
리드: 한미약품
- 3상조기 종료· GastritisEfficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
리드: 대웅제약
- 1/2상조기 종료· Acute Myeloid LeukemiaClinical Study of CWP232291 in Acute Myeloid Leukemia Patients
리드: JW중외제약
- 4상조기 종료· Metabolic SyndromeA Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
리드: 유한양행
- 1/2상조기 종료· Otitis MediaA Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea
리드: 유한양행
- 단계 미표기조기 종료· Breast NeoplasmsA Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
리드: 삼성바이오에피스
- 4상조기 종료· Ulcerative ColitisAzathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis
협력: 셀트리온
- 4상조기 종료· Coronary Artery DiseaseShort-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
협력: 종근당
- 1상조기 종료· HypertensionPK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
리드: 유한양행
- 2상조기 종료· Functional DyspepsiaA Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
리드: 유한양행
- 2상조기 종료· Non Small Cell Lung CancerPhase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
리드: 한미약품
- 단계 미표기조기 종료· Ankylosing SpondylitisAn Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
리드: 셀트리온
- 단계 미표기조기 종료· Crohn's DiseaseTo Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
리드: 셀트리온
- 단계 미표기조기 종료· Rheumatoid ArthritisAn Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
리드: 셀트리온
- 3상조기 종료· Abdominal Obesity Metabolic SyndromeEfficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
리드: 한미약품
- 2상조기 종료· Adenocarcinoma of Lung Stage IIIBNOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
협력: 한미약품
- 4상조기 종료· SchizophreniaThe Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
협력: 대웅제약
- 2상조기 종료· Cerebral InfarctionThe Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
협력: GC녹십자
- 1상조기 종료· Diffuse Large B-Cell LymphomaProvide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial
리드: 셀트리온
- 3상조기 종료· Severe SepsisGCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
리드: GC녹십자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.